351. Identification of anticancer peptides based on Random Relevance Vector Machines
- Author
-
Tianyi Zang, Yang Hu, Tianyi Zhao, and Cheng Liang
- Subjects
0301 basic medicine ,business.industry ,Computer science ,Stability (learning theory) ,Surgical operation ,Machine learning ,computer.software_genre ,Relevance vector machine ,03 medical and health sciences ,Identification (information) ,030104 developmental biology ,0302 clinical medicine ,030220 oncology & carcinogenesis ,SAFER ,Treatment effect ,Relevance (information retrieval) ,Artificial intelligence ,business ,computer - Abstract
Cancer is the most threat to human's health and life. At present, people have developed several ways to against cancer, such as surgical operation, radiotherapy and chemotherapy. However, cancers still cause highly mortality rate. A main part of the reason is that the traditional methods bring treatment effect as well as the negative effect. Recently, the anticancer peptides (ACPs) have been discovered which can be a new way to treat cancer. Since ACPs are natural biologics, they are safer than other methods. However, the experimental technology is an expensive way to find ACPs so we purpose a new machine learning method to identify the ACPs which named Random Relevance Vector Machines (RRVMs). The cross validations experiments show the high accuracy and stability of this new method.
- Published
- 2019
- Full Text
- View/download PDF